Idexx Laboratories | IDXX - Cash And Equivalent

Stock Price
568.25
Daily Change
-6.70 -1.17%
Monthly
2.00%
Yearly
30.04%
Q2 Forecast
553.82

Idexx Laboratories reported $180.07M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Accuray USD 63.34M 5.93M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Dentsply International USD 326M 37M Dec/2025
Dexcom USD 917.7M 918M Dec/2025
Edwards Lifesciences USD 2.4B 538M Mar/2026
Fujifilm JPY 160.88B 906M Sep/2025
Globus Medical USD 526.16M 154.39M Dec/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
Masimo USD 312.3M 162.7M Sep/2025
Neogen USD 159.9M 14.56M Dec/2025
Orthofix International USD 82.02M 19.16M Dec/2025
Phibro Animal Health USD 55.49M 17.28M Dec/2025
ResMed USD 1.42B 33.22M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Steris USD 423.7M 104.5M Dec/2025
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Zoetis USD 2.08B 649M Sep/2025